Metabolic bone diseases is the third most common endocrine diseases after diabetes and
thyroid diseases. More than 500 million people worldwide suffer from metabolic bone …

Osteoporosis, characterised by low bone mass, poor bone structure, and an increased risk
of fracture, is a major public health problem. There is increasing evidence that the influence …

Osteoclasts consume an amount of adenosine triphosphate (ATP) to perform their bone
resorption function in the development of osteoporosis. However, the mechanism underlying …

Osteoporosis is the most common metabolic bone disorder, with an estimated prevalence of
13.1% to 27.1% of women and 3.3% to 5.7% of men over the age of 50 affected. 1, 2 As a …

Bioactive constituents from Rhodiola rosea L. show a myriad of pharmacological effects on
diverse diseases. Rosavin has been linked to reduced osteoclastogenesis, while its role in …

The human skeleton is a dynamic and remarkably organized organ system that provides
mechanical support and performs a variety of additional functions. Bone tissue undergoes …

We aimed to identify protein biomarkers that could rapidly and accurately diagnose
osteoporosis patients (OPs) using a highly sensitive proteomic immunoassay. Four …

Discovery of molecular mechanisms of primary osteoporosis development is fundamental to
understand the pathogenesis of musculoskeletal diseases in general and for identifying key …

Аннотация Раскрытие молекулярных механизмов развития первичного остеопороза
имеет фундаментальное значение как с точки зрения понимания патогенеза …